NTLA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Intellia Therapeutics (NTLA) Earnings Date & Reports

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NTLA is expected to report earnings to fall 3.64% to -105 cents per share on July 31

Intellia Therapeutics NTLA Stock Earnings Reports

Q2'25

Est.

$-1.06

Q1'25

Beat

by $0.17

Q4'24

Beat

by $0.07

Q3'24

Beat

by $0.05

Q2'24

Missed

by $0.30

The last earnings report on May 08 showed earnings per share of -110 cents, beating the estimate of -126 cents. With 2.46M shares outstanding, the current market capitalization sits at 880.46M.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+30%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

NTLA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NTLA
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for NTLA (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of proprietary, potentially curative therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

40 Erie Street

Phone

+1 857 285-6200

Employees

526

Web

https://www.intelliatx.com